NCT07135024

Brief Summary

The aim of the registry is a multicenter, prospective long-term data collection of patients suspected neurovascular conflict and referred for possible microvascular decompression (Jannetta procedure). The registry relies exclusively on routinely collected clinical data, which are gathered in a standardized and privacy-compliant manner as part of everyday clinical practice. By systematically compiling this information across multiple centers, valuable insights into the effectiveness, potential side effects, and long-term outcomes of this surgical treatment can be gained. The registry will serve as a foundation for future scientific analyses and is intended to help answer relevant research questions regarding the treatment of trigeminal neuralgia based on solid evidence.

Trial Health

67
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,001

participants targeted

Target at P75+ for all trials

Timeline
90mo left

Started Oct 2025

Longer than P75 for all trials

Geographic Reach
2 countries

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
Oct 2025Oct 2033

First Submitted

Initial submission to the registry

August 5, 2025

Completed
16 days until next milestone

First Posted

Study publicly available on registry

August 21, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2030

Expected
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2033

Last Updated

August 21, 2025

Status Verified

August 1, 2025

Enrollment Period

5 years

First QC Date

August 5, 2025

Last Update Submit

August 13, 2025

Conditions

Keywords

Trigeminal NeuralgiaRegistryprospective studyeligibility determinationefficacy, treatmentFollow-Up Studiesindicationmicrovascular decompressionJannettatic douloureuxhemifacial spasmneurovascular conflictglossopharyngeal neuralgia

Outcome Measures

Primary Outcomes (2)

  • Pain relief after surgical treatment

    Efficacy of microvascular decompression surgery, defined by the change in pain as assessed by the patient using the Visual Analog Scale (VAS) from 0 to 100 mm, with higher scores representing worse outcomes.

    From enrolment to last follow-up 5 yrs after surgery

  • Face specific pain relief after surgical treatment

    Efficacy of microvascular decompression surgery, defined by the change in facial pain and pain interference as assessed by the patient using the Brief Pain Inventory-Facial (BPI-Facial), with numerical scores ranging from 0 to 10, where higher scores represent worse outcomes.

    From enrolment to last follow-up 5 yrs after surgery

Secondary Outcomes (4)

  • Surgical complications

    three months after index surgery

  • Need for additional treatment

    5 years after index surgery

  • Patient satisfaction

    5yrs after index surgery

  • Effect of surgical treatment on quality of life

    5 years after index surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study cohort will be selected from local Department of Neurosurgery of participating hospitals

You may qualify if:

  • suspected neurovascular conflict
  • signed consent for further use of routine clinical data as accepted by local regulations

You may not qualify if:

  • refusal of further use of routine clinical data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Dept. of Neurosurgery, RWTH Aachen University Hospital, RWTH Aachen University

Aachen, North Rhine-Westphalia, 52074, Germany

Location

Dept. of Neurosurgery, Cantonal Hospital Aarau

Aarau, Canton of Aargau, 5001, Switzerland

Location

MeSH Terms

Conditions

Trigeminal NeuralgiaFacial PainGlossopharyngeal Nerve DiseasesHemifacial Spasm

Condition Hierarchy (Ancestors)

Trigeminal Nerve DiseasesFacial NeuralgiaFacial Nerve DiseasesMouth DiseasesStomatognathic DiseasesCranial Nerve DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSpasmNeuromuscular Manifestations

Central Study Contacts

Stefanie Pflugi

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Head of Neurosurgery

Study Record Dates

First Submitted

August 5, 2025

First Posted

August 21, 2025

Study Start

October 1, 2025

Primary Completion (Estimated)

October 1, 2030

Study Completion (Estimated)

October 1, 2033

Last Updated

August 21, 2025

Record last verified: 2025-08

Locations